Company Overview and News

1
TECH / Bio-Techne Corp null

2018-05-31 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"[email protected],"!O8FH-/#PO3&EN96%R:7IE9" [email protected],S,V M.#DO3R Q,2]%(#(X,S([email protected],B]4(#,S,[email protected]@6R [email protected],30X73X^#65N M9&]B:@[email protected](" @(" @(" @(" @(" @(" @#0HQ-B P(&]B:@T\/"]$96-O9&50 M87)M7!E+UA2968O5ULQ(#(@,5T^/G-T('$UPH&)D:&&2 E#(Q,_QEW_P<(, "1G [email protected] M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')[email protected]*, T*)25%3T8-"B @(" @ M(" @#0HQ.2 P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22 X,R],96YG [email protected]@-CDO4R T.
TECH

1
TECH / Bio-Techne Corp null

2018-05-31 sec.gov
tech20180222_corresp.htm February
TECH

1
TECH / Bio-Techne Corp null

2018-05-31 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"[email protected],"!O8FH-/#PO3&EN96%R:7IE9" [email protected],S,X M-3 O3R Q,2]%(#(X,S([email protected],B]4(#,[email protected]@6R [email protected],34P73X^#65N M9&]B:@[email protected](" @(" @(" @(" @(" @(" @#0HQ-B P(&]B:@T\/"]$96-O9&50 M87)M7!E+UA2968O5ULQ(#(@,5T^/G-T('$UVH&)D:&&2 E#(Q,_QEW_P<(, "[email protected][email protected] M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')[email protected]*, T*)25%3T8-"B @(" @ M(" @#0HQ.2 P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22 X,R],96YG [email protected]@-S$O4R T.
TECH

1
TECH / Bio-Techne Corp null

2018-05-31 sec.gov
tech20180405_corresp.htm Ap
TECH

1
TECH / Bio-Techne Corp null

2018-05-31 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C<@,"!O8FH-/#PO3&EN96%R:7IE9" [email protected],S$X M,#
TECH

1
TECH / Bio-Techne Corp FORM SD

2018-05-28 sec.gov
tech20180525_sd.htm
TECH

1
TECH / Bio-Techne Corp FORM 10-Q (Quarterly Report)

2018-05-09 sec.gov
tech20180331_10q.htm Table of Contents
TECH

1
Bio-Techne (TECH) Q3 2018 Results - Earnings Call Transcript

2018-05-02 seekingalpha
Good morning, everyone, and welcome to the Bio-Techne Earnings Conference Call for the Third Quarter of Fiscal Year 2018. At this time, all participants have been placed in a listen-only mode and the call will be opened for questions following management's prepared remarks. I'll remind you that today's call is being recorded.
TECH

1
TECH / Bio-Techne Corp FORM 8-K (Current Report)

2018-05-02 sec.gov
tech20180501_8k.htm
TECH

1
TECH / Bio-Techne Corp FORM 8-K (Current Report)

2018-04-24 sec.gov
tech20180424_8k.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
TECH

7
Why the National Institute of Health New Budget Looks So Promising

2018-03-26 247wallst
According to a recent analyst report by Janney, the National Institute of Health (NIH) budget that was approved last Friday could be a big boost for some select biopharma stocks. The budget is said to be the best in 15 years and that the momentum is strong under the president and Republican leadership.
TMO TECH HBIO ILMN

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

12h - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

13h - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Silicon Investor Message Boards

This table lists all message boards related to TECH / Bio-Techne Corp on message board site Silicon Investor.

biotech firesales Technology Stocks u0026 Market Talk With Don Wolanchuk
Biotech Valuation Neptune Technologies u0026 Bioressources Inc. - NTB.V
The *NEW* Frank Coluccio Technology Forum StrikeForce Technologies
Reliq Health Technologies Inc Underexposed Technical Analysis
biotech fireworks Verde Agritech
CUSIP: 09073M104